AEON Biopharma, Inc. — Form D

AEON Biopharma, Inc. of IRVINE, CA, a company, filed a Form D exempt-offering notice with the SEC on 2016-08-10. The offering totals $55.0M, of which $5.5M was reported sold. Industry: Other Health Care.

Offering

Issuer

Officers, directors & promoters (31)

Showing 25 of 31 people.

NameRoleLocation
Juliet Tammenoms BakkerDirectorIrvine, CA
Simone S BlankDirectorIrvine, CA
Christopher Tammenoms CoxDirectorIrvine, CA
ROBERT E GRANTDirectorNEWPORT BEACH, CA
Bosun Tammenoms HauDirectorIrvine, CA
Robert S HaymanDirectorIrvine, CA
Hans S KeirsteadDirectorIrvine, CA
Richard S LindstromDirectorIrvine, CA
William E LinkDirectorIrvine, CA
Vikram S MalikDirectorIrvine, CA
Patrick S MaxwellDirectorIrvine, CA
Bill Tammenoms RichardsonDirectorIrvine, CA
Dennis Tammenoms WolfDirectorIrvine, CA
Craig Tammenoms KussmanExecutive OfficerIrvine, CA
William E LinkExecutive OfficerIrvine, CA
Robert Tammenoms RhatiganExecutive OfficerIrvine, CA
Alex WilsonExecutive OfficerMiami, FL
Jost FischerDirectorIrvine, CA
Robert GrantDirectorSonoma, CA
Darren O'BrienDirectorIrvine, CA
Simone BlankDirectorIrvine, CA
Marc ForthExecutive OfficerIrvine, CA
Vikram MalikDirectorIrvine, CA
Richard TaketaDirectorIrvine, CA
Chris CarrExecutive OfficerIrvine, CA

Other filings by this issuer (6)

FiledFormOfferingSold
2022-08-11D$30.0M$30.0M
2022-08-11D$25.0M$24.5M
2021-05-13D/A$30.0M$30.0M
2020-08-31D$25.0M$25.0M
2015-11-20D$150.0M$80.1M
2015-01-22D$40.5M$27.0M

More